The Latest Analyst Ratings for Rallybio
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinions on Rallybio (NASDAQ:RLYB) stock, with an average price target of $17.25, representing a 33.65% decrease from the previous average price target of $26.00. The current price of Rallybio is $6.1775.
June 26, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rallybio (NASDAQ:RLYB) has received 4 analyst ratings in the past 3 months, with an average price target of $17.25, down 33.65% from the previous target of $26.00.
The average price target of $17.25 for Rallybio, as determined by 4 analysts, represents a significant upside potential compared to the current price of $6.1775. This could lead to a positive short-term impact on the stock price, as investors may see the potential for growth based on these analyst ratings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100